Medical Design Technology -
10 Nov 2016 17:05
News The young scientists of Tomsk Polytechnic University propose to resolve implant rejection problems by covering implants with biologically active compound, which is an analogue to the cytokine interleukin 4. Contributed Author: Tomsk Polytechnic University Topics: Implantables
Share this Article